Oncology day care & infusion
A chair, a protocol and a defined observation plan.
KPCIRC’s day-care and infusion model is designed for prescribed treatments and selected supportive therapies delivered in an appropriately equipped setting. Services, locations, hours and eligibility are confirmed site by site.
A treatment chair is part of a clinical pathway, not just a seat. The model is described by its care pathway and operational safeguards, not by chair count alone.
Services that may be considered within a confirmed programme
- Prescribed chemotherapy, immunotherapy and biologic treatment sessions, where the facility and responsible clinician are equipped and authorised to provide them.
- Selected supportive infusions, which may include IV iron, hydration, electrolyte replacement, antiemetic or symptom-relief infusions and selected bone-modifying therapies, when clinically indicated.
- Observation and nursing or medical support associated with an agreed treatment session.
- Selected port, PICC and central-line care, and infusion-pump disconnection or flushing, only where staff competencies and facility protocols support them.
- High-acuity or desensitisation pathways, only where a specialist-led protocol, suitable staffing, monitoring and emergency-response capability are confirmed.
The infusion-chair model
Preliminary service-planning bands drawn from the KPCIRC service brochure.
| Session band | Indicative duration | Planning purpose | Operations note |
|---|---|---|---|
| Short session | Up to 2 hours | Selected infusions or treatment sessions with shorter administration and protocol-defined observation. | Confirm chair allocation, staffing, monitoring and discharge criteria for the prescribed therapy. |
| Standard session | 2–4 hours | Planned outpatient treatment with pre-assessment, prescribed administration and observation as required. | Actual duration depends on the medicine, regimen and required monitoring. |
| Extended session | 4–6 hours | Regimens or supportive treatment that need longer administration or observation. | Confirm capacity and whether the site can safely provide the full session. |
| High-acuity or desensitisation | More than 6 hours | Selected complex or desensitisation pathways where a specialist protocol and suitable facility capability exist. | Offered only after staff, emergency readiness, equipment and protocols are verified at the named site. |
These are scheduling categories for planning. They are not a clinical risk score, a guarantee of chair availability or a prediction of an individual’s treatment duration. The prescription, product label, protocol, patient condition and required observation determine the actual schedule.
What a planned session requires
- Identity, prescription or order, regimen, indication and required pre-treatment checks.
- Review of relevant history, allergies, prior infusion reactions and required results.
- Medicine handling, staff competencies, access devices, equipment and protocol-matched administration.
- Observation and monitoring appropriate to the prescribed treatment and the person’s clinical risk.
- A documented escalation route, emergency arrangements and discharge criteria.
- A documented handoff, written post-session instructions and a follow-up plan.
Photograph is illustrative and is not a KPCIRC facility.
Patient journey: from booking to discharge
Enquiry and service fit
Confirm the prescribed service, treating clinician, active site, required records and whether the service can be supported.
Pre-visit review
Gather the order and pre-treatment information through the approved workflow. Checks depend on the regimen and protocol.
Arrival and verification
Confirm identity, treatment order, reaction history, consent and baseline assessments.
Chair and administration
The authorised team administers the prescribed therapy with approved monitoring and documentation.
Observation and escalation
Observe for the time required by the protocol; act on the facility’s approved reaction and escalation procedure.
Discharge and follow-up
Written instructions, how to contact the responsible team, and the next appointment or follow-up.
Possible institutional day-care models
Planning models for discussion with a hospital, not a statement that every model is operating. A model is activated only after site readiness and clinical governance are confirmed.
| Operating model | How it may work | Readiness condition |
|---|---|---|
| Dedicated oncology day-care unit | A defined area with planned chair capacity, staff allocation, treatment and observation workflow and a named clinical lead. | Verified premises, chair capacity, medicine handling, emergency readiness, staffing and approved protocols. |
| Scheduled chair sessions in an existing unit | Planned use of an existing suitable day-care or infusion area during agreed session times. | Host facility and service team agree responsibilities, records, equipment, patient flow and escalation. |
| Sessional specialist or visiting service | Defined clinic or treatment sessions supported by a responsible specialist and an approved operating arrangement. | Not advertised until clinician availability, site support and scope are confirmed. |
| Referral or partner-facility pathway | Where a therapy cannot safely be offered at the first site, referral to a suitable facility may be discussed. | The service is never presented as available at KPCIRC if it is only coordinated or referred elsewhere. |
What to ask before booking
- Is the exact prescribed medicine or treatment available at the named location?
- What records, laboratory results, prescriptions or approvals are required?
- How long is the planned chair session, including required observation?
- Who is responsible for prescribing, administration, monitoring and follow-up?
- What is included in the service fee, and what is billed separately?
- What should I do if a new symptom or reaction occurs before or after the visit?
Facility readiness and safety
A site is listed for infusion treatment only after KPCIRC confirms the treatment scope, qualified personnel, medication handling and storage, infection control, monitoring equipment, emergency response and escalation, documentation, consent, chair and session availability, and a named clinical lead. Not every treatment is available at every location.
Short explainers, in production
- Day care and the infusion-chair modelAbout 60–75 seconds
- Treatment-specific prophylaxis and high-risk observationAbout 60–75 seconds
Representative photographs of hospital settings in India and of IV access. They do not show KPCIRC premises or patients.